Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
Goebel,G.; Berger,R.; Strasak,A.M.; Egle,D.; Müller-Holzner,E.; Schmidt,S.; Rainer,J.; Presul,E.; Parson,W.; Lang,S.; Jones,A.; Widschwendter,M.; Fiegl,H.;
Background:The role of CHAC1 (cation transport regulator-like protein 1), a recently identified component of the unfolded protein response (UPR) pathway, in gynaecological cancers has not yet been characterised. Now, this work illustrates CHAC1 mRNA expression and associated clinical outcome in breast and ovarian cancer.Methods:The prognostic value of CHAC1 and its two transcript variants was investigated in 116 breast and 133 ovarian tissues using quantitative real-time reverse-transcriptase PCR.
[Read More]